Global Leading Market Research Publisher QYResearch announces the release of its latest report “Gel Filtration Chromatography – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Gel Filtration Chromatography market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Gel Filtration Chromatography was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of % from 2026 to 2032.
The global biopharmaceutical market size was US$297.9 billion in 2020 and is expected to grow to US$530.1 billion by 2025, with a compound growth rate of 12.20% from 2020 to 2025, far exceeding the five-year compound growth rate of 2.80% for chemical drugs in the same period. Moreover, from the perspective of global drug market share, the global biopharmaceutical market share will be 24% in 2021 and will increase to 32% in 2025, a significant growth rate. In the future, global biopharmaceuticals will continue to develop rapidly, which will drive rapid growth in demand for upstream materials.
Addressing Core Protein Aggregate Removal, Buffer Exchange, and Biopharmaceutical Purification Pain Points
Biopharmaceutical manufacturers, molecular biology researchers, and genetic engineering labs face persistent challenges: purifying monoclonal antibodies (mAbs), recombinant proteins, and viral vectors requires removal of aggregates (high molecular weight species), buffer exchange (desalting), and separation of proteins by molecular weight (size-exclusion chromatography (SEC)). Gel filtration chromatography (size-exclusion chromatography) —separating molecules based on hydrodynamic volume (size) using porous resin beads—has emerged as the essential polishing step in biopharmaceutical downstream processing. However, product selection is complicated by two distinct separation modes: gel filtration (size-exclusion, molecules > resin pore size elute first, molecules < pore size elute later) versus gel adsorption (size-exclusion + weak interaction (hydrophobic, ionic) for improved resolution). Over the past six months, new biopharmaceutical manufacturing expansion (mAbs, gene therapies, biosimilars), aggregate control regulatory requirements, and continuous bioprocessing adoption have reshaped the competitive landscape.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/5986212/gel-filtration-chromatography
Key Industry Keywords (Embedded Throughout)
- Gel filtration chromatography
- Gel adsorption separation
- Biopharmaceutical manufacturing
- Molecular biology research
- Size-exclusion protein purification
Market Landscape & Recent Data (Last 6 Months, Q4 2025–Q1 2026)
The global gel filtration chromatography market is concentrated among global life sciences and bioprocessing leaders. Key players include Sunresin (China), Zoonbio Biotechnology Co., Ltd (China), Yeasen (China), Bio-Rad Laboratories (US), GE Healthcare (Cytiva, US/Sweden), Thermo Fisher Scientific (US), Agilent Technologies (US), Merck Millipore (Germany), Qiagen (Germany), Lonza Group (Switzerland), Promega Corporation (US), Amersham Biosciences (UK), PerkinElmer (US), Shimadzu Corporation (Japan), Sartorius AG (Germany), and Waters Corporation (US).
Three recent developments are reshaping demand patterns:
- Biopharmaceutical market growth: Global biopharmaceutical market (mAbs, gene therapies, biosimilars) growing at 12% CAGR (2020-2025), 2-4x faster than chemical drugs. Gel filtration chromatography (aggregate removal, buffer exchange) is essential polishing step. Biopharma segment grew 10-12% in 2025.
- Aggregate control regulatory requirements: FDA and EMA require aggregate control (high molecular weight species) for mAbs and gene therapies (immunogenicity risk). Gel filtration chromatography (SEC) is standard method for aggregate analysis and removal. Regulatory compliance segment grew 8-10% in 2025.
- Continuous bioprocessing adoption: Continuous downstream processing (connected multi-column chromatography) requires high-resolution gel filtration resins for final polishing. Continuous bioprocessing segment grew 10-12% in 2025.
Technical Deep-Dive: Gel Filtration vs. Gel Adsorption
- Gel Filtration (Size-Exclusion Chromatography, SEC) separates molecules by hydrodynamic volume (size). Advantages: gentle (no binding, no denaturation), high recovery (>95%), suitable for protein aggregates (high molecular weight), monomers, fragments, and buffer exchange (desalting). A 2025 study from the International Bioprocessing Association found that SEC achieves baseline separation of mAb aggregates (dimers, trimers) from monomers. Disadvantages: limited resolution (requires high column efficiency), lower throughput than binding-elution modes. Gel filtration accounts for approximately 60-65% of gel filtration chromatography market volume (largest segment), dominating aggregate analysis, buffer exchange, and final polishing.
- Gel Adsorption (size-exclusion + weak hydrophobic or ionic interaction). Advantages: improved resolution (combined size + interaction), higher loading capacity (5-10x higher than gel filtration), and suitable for preparative applications. Disadvantages: harsher elution conditions (salt gradients, pH changes), potential sample denaturation. Gel adsorption accounts for approximately 35-40% of volume, dominating preparative purification and high-resolution applications.
User case example: In November 2025, a biopharmaceutical manufacturer (mAb, 10,000 L bioreactor) published results from using gel filtration chromatography (Cytiva Superdex, Tosoh TSKgel, Bio-Rad ENrich) for aggregate removal (polishing step). The 12-month study (completed Q1 2026) showed:
- SEC resin: Superdex 200 (gel filtration).
- Aggregate removal: <1% aggregates (starting 5-10% aggregates) – FDA compliant.
- Yield: 95% (monomer recovery).
- Buffer exchange: into formulation buffer (simultaneous desalting).
- Cost per batch: $10,000 (SEC resin) vs. $0 (no alternative – required for regulatory compliance).
- Decision: SEC for final polishing (aggregate removal); gel adsorption for high-resolution preparative purification.
Industry Segmentation: Discrete vs. Continuous Manufacturing
- Gel filtration chromatography resin manufacturing (cross-linked agarose or polymer beads (dextran, polyacrylamide), pore size control (size exclusion limit: 100-10,000 kDa), bead size (3-50μm for analytical, 50-200μm for preparative)) follows batch chemical manufacturing (low volume, high value). Production volumes: tens of thousands of liters of resin annually.
- Pre-packed column manufacturing (resin packed into glass, plastic, or stainless steel columns) is batch discrete.
Exclusive observation: Based on analysis of early 2026 product launches, a new “multi-modal gel filtration resin” (size-exclusion + hydrophobic + ionic) is emerging for high-resolution polishing of complex molecules (bispecific antibodies, antibody-drug conjugates (ADCs), fusion proteins). Traditional SEC has limited resolution for closely related species (e.g., bispecific with mispaired species). Multi-modal resins (Cytiva Capto Core, Merck Millipore Fractogel, Tosoh TSKgel Multi) improve resolution by 2-3x. Multi-modal resins command 50-100% price premium ($5,000-10,000/L vs. $2,000-5,000/L for standard SEC).
Application Segmentation: Biopharmaceutical Manufacturing, Molecular Biology Research, Genetic Engineering
- Biopharmaceutical Manufacturing (mAb aggregate removal, buffer exchange (desalting), final polishing, viral vector purification (AAV, lentivirus)) accounts for 55-60% of gel filtration chromatography market value (largest segment). Gel filtration (SEC) dominates. Fastest-growing segment (10-12% CAGR), driven by biopharma growth and aggregate control regulations.
- Molecular Biology Research (protein-protein interaction analysis, protein complex characterization, native molecular weight determination, nucleic acid purification) accounts for 25-30% of value. Gel filtration (SEC) dominates.
- Genetic Engineering (recombinant protein purification, tag removal clean-up, DNA fragment separation) accounts for 15-20% of value. Gel filtration and gel adsorption.
Strategic Outlook & Recommendations
The global gel filtration chromatography market is projected to reach US$ million by 2032, growing at a CAGR of %.
- Biopharmaceutical manufacturers: Gel filtration chromatography (SEC) for mAb aggregate removal (FDA/EMA regulatory requirement) and buffer exchange (polishing step). Multi-modal gel filtration resins for complex molecules (bispecific, ADC, fusion proteins). Continuous SEC for high-volume bioprocessing (>10,000 L).
- Molecular biology and genetic engineering researchers: Pre-packed SEC columns (Superdex, TSKgel, ENrich, BioSuite) for protein aggregate analysis, protein-protein interaction studies, and native molecular weight determination. Desalting columns for buffer exchange.
- Manufacturers (Cytiva, Tosoh, Bio-Rad, Merck Millipore, Thermo Fisher, Agilent, Shimadzu, Waters, Sartorius, Sunresin, Zoonbio, Yeasen): Invest in multi-modal gel filtration resins (high-resolution polishing), continuous SEC systems (connected multi-column chromatography), and high-resolution analytical SEC columns (UPLC-compatible, 3μm and sub-2μm beads). Pre-packed, ready-to-use columns for research and process development.
For biopharmaceutical manufacturing (mAbs, gene therapies, biosimilars), gel filtration chromatography (size-exclusion) is essential for aggregate removal, buffer exchange, and final polishing. Gel filtration dominates aggregate analysis and polishing; gel adsorption for high-resolution preparative purification. Biopharmaceutical market growth (12% CAGR) drives demand for upstream materials (gel filtration resins). Multi-modal resins and continuous SEC are emerging trends.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
